• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经内分泌肿瘤低级别和高级别发病率呈上升趋势。

Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms.

机构信息

Section of Hygiene, Institute of Public Health, Rome, 00168, Italy.

Tisch Cancer Institute, New York, NY, 10029, USA.

出版信息

Endocrine. 2017 Nov;58(2):368-379. doi: 10.1007/s12020-017-1273-x. Epub 2017 Mar 16.

DOI:10.1007/s12020-017-1273-x
PMID:28303513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5671554/
Abstract

PURPOSE

The incidence of neuroendocrine neoplasms is increasing. This work aimed at: (i) establishing worldwide incidence trend of low-grade neuroendocrine neoplasms; (ii) defining the incidence and temporal trend of high-grade neuroendocrine neoplasms in USA utilizing the Surveillance Epidemiology and End Results database; (iii) comparing trends for low-grade vs. high-grade neuroendocrine neoplasms.

METHODS

We conducted a literature search on MEDLINE and Scopus databases and incidence trends were plotted for 1973-2012. The Surveillance Epidemiology and End Results database was used to identify incidence rates in USA for 1973-2012. Incidence rates were stratified according to histological grade, gender and ethnicity. Trends were summarized as annual percent change and corresponding 95% confidence interval.

RESULTS

11 studies were identified involving 72,048 cases; neuroendocrine neoplasm incidence rates increased over time in all countries for all sites, except for appendix. In Surveillance Epidemiology and End Results low-grade neuroendocrine neoplasm incidence rate increased from 1.09 in 1973 to 3.51 per 100,000 in 2012. During this interval, high-grade neuroendocrine neoplasm incidence rate increased from 2.54 to 10.52 per 100,000. African Americans had the highest rates of digestive neuroendocrine neoplasms with male prevalence in high-grade.

CONCLUSIONS

Our data indicate an increase in the incidence of neuroendocrine neoplasms as a worldwide phenomenon, affecting most anatomical sites and involving both low-grade and high-grade neoplasms.

摘要

目的

神经内分泌肿瘤的发病率正在上升。本研究旨在:(i)确定低级别神经内分泌肿瘤的全球发病率趋势;(ii)利用监测、流行病学和最终结果数据库定义美国高级别神经内分泌肿瘤的发病率和时间趋势;(iii)比较低级别与高级别神经内分泌肿瘤的趋势。

方法

我们在 MEDLINE 和 Scopus 数据库中进行了文献检索,并绘制了 1973 年至 2012 年的发病率趋势。利用监测、流行病学和最终结果数据库确定了 1973 年至 2012 年美国的发病率。根据组织学分级、性别和种族对发病率进行分层。趋势以年百分比变化和相应的 95%置信区间进行总结。

结果

共确定了 11 项研究,涉及 72048 例病例;除阑尾外,所有国家的所有部位神经内分泌肿瘤的发病率随着时间的推移都在增加。在监测、流行病学和最终结果中,低级别神经内分泌肿瘤的发病率从 1973 年的 1.09 增加到 2012 年的 3.51/10 万。在此期间,高级别神经内分泌肿瘤的发病率从 2.54 增加到 10.52/10 万。非裔美国人的消化系统神经内分泌肿瘤发病率最高,且高级别肿瘤中男性患病率较高。

结论

我们的数据表明,神经内分泌肿瘤的发病率呈全球性上升趋势,影响大多数解剖部位,涉及低级别和高级别肿瘤。

相似文献

1
Increased incidence trend of low-grade and high-grade neuroendocrine neoplasms.神经内分泌肿瘤低级别和高级别发病率呈上升趋势。
Endocrine. 2017 Nov;58(2):368-379. doi: 10.1007/s12020-017-1273-x. Epub 2017 Mar 16.
2
Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.胃神经内分泌肿瘤的发病率和生存趋势:SEER 数据库中 3523 例患者的分析。
Eur J Surg Oncol. 2018 Oct;44(10):1628-1633. doi: 10.1016/j.ejso.2018.01.082. Epub 2018 Jan 31.
3
Pancreatic neuroendocrine tumours: Grade is superior to T, N, or M status in predicting outcome and selecting patients for chemotherapy:A retrospective cohort study in the SEER database.胰腺神经内分泌肿瘤:在预测结局和选择化疗患者方面,分级优于 T、N 或 M 状态:SEER 数据库中的回顾性队列研究。
Int J Surg. 2019 Jun;66:103-109. doi: 10.1016/j.ijsu.2019.03.006. Epub 2019 Mar 11.
4
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.美国神经内分泌肿瘤患者的发病率、患病率和生存结局趋势。
JAMA Oncol. 2017 Oct 1;3(10):1335-1342. doi: 10.1001/jamaoncol.2017.0589.
5
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.胰腺神经内分泌肿瘤(PNETs):发病率、预后及近期生存率改善趋势
Ann Oncol. 2008 Oct;19(10):1727-33. doi: 10.1093/annonc/mdn351. Epub 2008 May 30.
6
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
7
Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria.使用当前编码标准的胃肠胰神经内分泌肿瘤的流行病学与分类
Br J Surg. 2016 Feb;103(3):226-32. doi: 10.1002/bjs.10034. Epub 2015 Oct 29.
8
Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis.结肠和直肠神经内分泌癌患者的生存情况:一项基于人群的分析。
Dis Colon Rectum. 2015 Mar;58(3):294-303. doi: 10.1097/DCR.0000000000000298.
9
Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database.肺神经内分泌肿瘤的发病率和患病率:一项美国商业保险理赔数据库分析。
BMC Pulm Med. 2018 Aug 13;18(1):135. doi: 10.1186/s12890-018-0678-5.
10
Gastric Neuroendocrine Tumors (G-Nets): Incidence, Prognosis and Recent Trend Toward Improved Survival.胃神经内分泌肿瘤(G-Nets):发病率、预后及生存改善的近期趋势
Cell Physiol Biochem. 2018;45(1):389-396. doi: 10.1159/000486915. Epub 2018 Jan 22.

引用本文的文献

1
Factors Influencing Resection Time in Endoscopic Submucosal Dissection for Rectal Neuroendocrine Tumors.影响直肠神经内分泌肿瘤内镜黏膜下剥离术切除时间的因素
DEN Open. 2025 Sep 2;6(1):e70199. doi: 10.1002/deo2.70199. eCollection 2026 Apr.
2
Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study-TCOG T1214 study.台湾胃肠胰神经内分泌肿瘤的临床结局:一项多中心注册研究——TCOG T1214研究
Cancer. 2025 Sep 1;131(17):e70019. doi: 10.1002/cncr.70019.
3
Epidemiological insights and survival patterns in neuroendocrine neoplasia: a geographic perspective.

本文引用的文献

1
Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implications.3 级胃肠胰神经内分泌癌的异质性:新的认识和治疗意义。
Cancer Treat Rev. 2016 Nov;50:61-67. doi: 10.1016/j.ctrv.2016.08.006. Epub 2016 Aug 28.
2
Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.胃肠胰高分化3级神经内分泌肿瘤:综述与立场声明
Oncologist. 2016 Oct;21(10):1191-1199. doi: 10.1634/theoncologist.2015-0476. Epub 2016 Jul 8.
3
The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories.
神经内分泌肿瘤的流行病学见解与生存模式:地域视角
Endocr Oncol. 2025 Aug 5;5(1):e250039. doi: 10.1530/EO-25-0039. eCollection 2025 Jan.
4
New Horizons: The Evolution of Nuclear Medicine in the Diagnosis and Treatment of Pancreatic Neuroendocrine Tumors-A Case Report.新视野:核医学在胰腺神经内分泌肿瘤诊断与治疗中的进展——病例报告
J Clin Med. 2025 Jun 22;14(13):4432. doi: 10.3390/jcm14134432.
5
Gender-based differences in survival outcomes of rectal neuroendocrine tumors: a population-based analysis.直肠神经内分泌肿瘤生存结局的性别差异:一项基于人群的分析。
Discov Oncol. 2025 Jun 5;16(1):1008. doi: 10.1007/s12672-025-02842-3.
6
A Case of a Neuroendocrine Tumor in a Liver Transplant Patient: Diagnostic and Management Difficulties.一例肝移植患者神经内分泌肿瘤病例:诊断与管理难题
Life (Basel). 2025 Mar 7;15(3):421. doi: 10.3390/life15030421.
7
Everolimus in the Treatment of Neuroendocrine Tumors: Lights and Shadows.依维莫司治疗神经内分泌肿瘤:亮点与阴影
Biomedicines. 2025 Feb 12;13(2):455. doi: 10.3390/biomedicines13020455.
8
Incidence trends and relative survival of colorectal neuroendocrine neoplasms: A population-based study using German cancer registry data.结直肠神经内分泌肿瘤的发病率趋势及相对生存率:一项基于德国癌症登记数据的人群研究。
Int J Cancer. 2025 Jul 1;157(1):116-125. doi: 10.1002/ijc.35372. Epub 2025 Feb 20.
9
Predictive and prognostic nomogram models for liver metastasis in colorectal neuroendocrine neoplasms: a large population study.结直肠神经内分泌肿瘤肝转移的预测和预后列线图模型:一项大型人群研究
Front Endocrinol (Lausanne). 2025 Jan 7;15:1488733. doi: 10.3389/fendo.2024.1488733. eCollection 2024.
10
Small bowel neuroendocrine tumor presenting with chronic diarrhea and mesenteric ischemia: A case report.以慢性腹泻和肠系膜缺血为表现的小肠神经内分泌肿瘤:一例报告
Clin Case Rep. 2024 Oct 31;12(11):e9508. doi: 10.1002/ccr3.9508. eCollection 2024 Nov.
3级胃肠胰神经内分泌肿瘤的临床病理异质性:形态学分化和增殖确定不同的预后类别。
Neuroendocrinology. 2017;104(1):85-93. doi: 10.1159/000445165. Epub 2016 Mar 5.
4
Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review.胃肠胰神经内分泌癌:全面综述。
Diagnostics (Basel). 2015 Apr 8;5(2):119-76. doi: 10.3390/diagnostics5020119.
5
Trends in Incidence of Neuroendocrine Neoplasms in Norway: A Report of 16,075 Cases from 1993 through 2010.挪威神经内分泌肿瘤发病率趋势:1993年至2010年16075例病例报告
Neuroendocrinology. 2017;104(1):1-10. doi: 10.1159/000442207. Epub 2015 Nov 13.
6
Current cigarette smoking among adults - United States, 2005-2014.成年人当前吸烟状况 - 美国,2005-2014 年。
MMWR Morb Mortal Wkly Rep. 2015 Nov 13;64(44):1233-40. doi: 10.15585/mmwr.mm6444a2.
7
Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria.使用当前编码标准的胃肠胰神经内分泌肿瘤的流行病学与分类
Br J Surg. 2016 Feb;103(3):226-32. doi: 10.1002/bjs.10034. Epub 2015 Oct 29.
8
Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis.神经内分泌肿瘤的风险因素:系统评价和荟萃分析。
Ann Oncol. 2016 Jan;27(1):68-81. doi: 10.1093/annonc/mdv505. Epub 2015 Oct 20.
9
Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms.G3 胃肠胰神经内分泌肿瘤患者的特征与治疗
Endocr Relat Cancer. 2015 Aug;22(4):657-64. doi: 10.1530/ERC-15-0119. Epub 2015 Jun 25.
10
The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.高级别(世界卫生组织G3级)胰腺神经内分泌肿瘤类别在形态学和生物学上具有异质性,包括高分化和低分化肿瘤。
Am J Surg Pathol. 2015 May;39(5):683-90. doi: 10.1097/PAS.0000000000000408.